AHS Cancer Control Alberta: Lung Neoplasms trials

The registry lists 16 Lung Neoplasms studies with AHS Cancer Control Alberta as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 8Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung CancerRecruitingNCT04952480Phase 2
• A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based ChemotherapyWithdrawnNCT02152059Phase 2
• A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung CancerStatus unknownNCT01624051Phase 2
• Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung CancerStatus unknownNCT01426841Phase 1
• Metabolism of Lipids in Advanced CancerTerminatedNCT00962234
• Hypofractionated Radiotherapy for Limited Stage Small Cell Lung CancerCompletedNCT00907569Phase 2
• Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung CancerCompletedNCT00888823Phase 1/2
• Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapyStatus unknownNCT00765986
• Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung CancerCompletedNCT00643396Phase 2
• Quantifying Lung Tumor Movement Under Deep Inspiration Breath HoldsCompletedNCT00643370
• Hypofractionated Radiotherapy for Small Cell Lung CancerCompletedNCT00469222Phase 1
• Cone Beam CT Scanning in Lung and Bladder Cancer.CompletedNCT00469066
• The Utility of FDG-PET for Radiation Treatment in NSCLCStatus unknownNCT00385164
• Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung TumoursCompletedNCT00351962Not applicable
• Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerCompletedNCT00123760Phase 2/3
• Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung CancerCompletedNCT00123747Phase 2